A blinded cross-over study of the effects of high dose simvastatin vs. atorvastatin on lipoprotein profiles, apolipoprotein B, apolipoprotein A1 and high sensitivity C-reactive protein.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Atorvastatin; Simvastatin
- Indications Low HDL cholesterol
- Focus Therapeutic Use
- 20 Jul 2011 Planned End Date changed from 1 Jun 2012 to 1 Jan 2012 as reported by ClinicalTrials.gov.
- 29 Apr 2011 Planned End Date changed from 1 Jan 2010 to 1 Jun 2012, according to the Oregon Health and Science University Institutional Review Board.
- 14 Jan 2010 New source identified and integrated (Oregon Health and Science University Institutional Review Board).